Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Presatovir for upper respiratory RSV infection in hematopoietic cell transplant recipients
MOH_2017-05-17_000423Phase 2Active, not recruiting
- Sponsor
- Gilead Sciences
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of presatovir in respiratory syncytial virus disease (RSV) (2 arms), sponsored by Gilead Sciences. Started Oct 2016; status: active, not recruiting.
02
Drugs
presatovir
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on MOH_2017-05-17_000423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-05-17_000423.